These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7870912)

  • 1. Effects of acute doses of oxiracetam in the scopolamine model of human amnesia.
    Preda L; Alberoni M; Bressi S; Cattaneo C; Parini J; Canal N; Franceschi M
    Psychopharmacology (Berl); 1993; 110(4):421-6. PubMed ID: 7870912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oxiracetam on scopolamine-induced amnesia in the rat in a spatial learning task.
    Pitsikas N; Algeri S
    Pharmacol Biochem Behav; 1992 Nov; 43(3):949-51. PubMed ID: 1448491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.
    Magnani M; Pozzi O; Biagetti R; Banfi S; Dorigotti L
    Psychopharmacology (Berl); 1992; 106(2):175-8. PubMed ID: 1549645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of L-alpha-glyceryl-phosphorylcholine on amnesia caused by scopolamine.
    Canal N; Franceschi M; Alberoni M; Castiglioni C; De Moliner P; Longoni A
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):103-7. PubMed ID: 2071257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of ascorbic acid and oxiracetam on scopolamine-induced amnesia in a habituation test in aged mice.
    de Angelis L; Furlan C
    Neurobiol Learn Mem; 1995 Sep; 64(2):119-24. PubMed ID: 7582819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A decrease in brain catecholamines prevents oxiracetam antagonism of the effects of scopolamine on memory and brain acetylcholine.
    Giovannini MG; Spignoli G; Carlà V; Pepeu G
    Pharmacol Res; 1991 Dec; 24(4):395-405. PubMed ID: 1805193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of scopolamine and nootropic drugs on rewarded alternation in a T-maze.
    Bartolini L; Risaliti R; Pepeu G
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1161-4. PubMed ID: 1475299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine attenuates scopolamine-induced memory impairment in humans.
    Riedel W; Hogervorst E; Leboux R; Verhey F; van Praag H; Jolles J
    Psychopharmacology (Berl); 1995 Nov; 122(2):158-68. PubMed ID: 8848531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxiracetam prevented the scopolamine but not the diazepam induced memory deficits in mice.
    Hlinák Z; Krejcí I
    Behav Brain Res; 2002 Jul; 133(2):395-9. PubMed ID: 12110475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes.
    Mintzer MZ; Griffiths RR
    Exp Clin Psychopharmacol; 2003 Feb; 11(1):56-72. PubMed ID: 12622344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative analysis of scopolamine-induced amnesia.
    Caine ED; Weingartner H; Ludlow CL; Cudahy EA; Wehry S
    Psychopharmacology (Berl); 1981; 74(1):74-80. PubMed ID: 6791209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
    Duka T; Ott H; Rohloff A; Voet B
    Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of scopolamine on matching to sample paradigm and related tests in human subjects.
    Koller G; Satzger W; Adam M; Wagner M; Kathmann N; Soyka M; Engel R
    Neuropsychobiology; 2003; 48(2):87-94. PubMed ID: 14504417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing between attentional and amnestic effects in information processing: the separate and combined effects of scopolamine and nicotine on verbal free recall.
    Rusted J; Eaton-Williams P
    Psychopharmacology (Berl); 1991; 104(3):363-6. PubMed ID: 1924643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose effects of triazolam and scopolamine on metamemory.
    Mintzer MZ; Kleykamp BA; Griffiths RR
    Exp Clin Psychopharmacol; 2010 Feb; 18(1):17-31. PubMed ID: 20158291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxiracetam in dementia: a double-blind, placebo-controlled study.
    Bottini G; Vallar G; Cappa S; Monza GC; Scarpini E; Baron P; Cheldi A; Scarlato G
    Acta Neurol Scand; 1992 Sep; 86(3):237-41. PubMed ID: 1414239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on human memory: the interactions of diazepam, scopolamine, and physostigmine.
    Ghoneim MM; Mewaldt SP
    Psychopharmacology (Berl); 1977 Mar; 52(1):1-6. PubMed ID: 403551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of scopolamine on verbal memory; a retrieval or acquisition deficit?
    Rusted JM; Warburton DM
    Neuropsychobiology; 1989; 21(2):76-83. PubMed ID: 2693994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling dementia: effects of scopolamine on memory and attention.
    Broks P; Preston GC; Traub M; Poppleton P; Ward C; Stahl SM
    Neuropsychologia; 1988; 26(5):685-700. PubMed ID: 3211287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine.
    Spignoli G; Pepeu G
    Pharmacol Biochem Behav; 1987 Jul; 27(3):491-5. PubMed ID: 3659072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.